What is Cogent Biosciences, Inc.'s investing cash flow?

Cogent Biosciences, Inc. (COGT) reported investing cash flow of -$36.46M in Q1 2026.

How has Cogent Biosciences, Inc.'s investing cash flow changed year-over-year?

Cogent Biosciences, Inc.'s investing cash flow decreased by 152.5% year-over-year, from $69.38M to -$36.46M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Cogent Biosciences, Inc. COGT Investing Cash Flow

Investing Cash Flow at other companies

PfizerPFE

$785M-76.0%

AmgenAMGN

-$716M-60.2%

IncyteINCY

-$88.2M-8,140%

Tango TherapeuticsTNGX

$9.64M-68.5%

CG OncologyCGON

-$334.85M-79.3%

Relay Therapeutics, Inc.RLAY

$32.9M-22.5%

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s investing cash flow?: Cogent Biosciences, Inc. (COGT) reported investing cash flow of -$36.46M in Q1 2026.
How has Cogent Biosciences, Inc.'s investing cash flow changed year-over-year?: Cogent Biosciences, Inc.'s investing cash flow decreased by 152.5% year-over-year, from $69.38M to -$36.46M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.